No Data
No Data
Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Rapport Therapeutics Inc Trading Halted, Volatility Trading Pause
Express News | Rapport Therapeutics : Intends to Initiate Additional Phase 2a Trial of Rap-219 in Bipolar Mania in Q3 2025 With Topline Data Expected in H1 of 2027
Express News | Rapport Therapeutics Announces Appointment of DR. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development
Press Release: Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Unlock the Full List